BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grohskopf LA, Alyanak E, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season. MMWR Recomm Rep 2019;68:1-21. [PMID: 31441906 DOI: 10.15585/mmwr.rr6803a1] [Cited by in Crossref: 195] [Cited by in F6Publishing: 179] [Article Influence: 65.0] [Reference Citation Analysis]
Number Citing Articles
1 Boikos C, Imran M, Nguyen VH, Ducruet T, Sylvester GC, Mansi JA. Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine in Individuals at High Risk of Influenza Complications in the 2018-2019 United States Influenza Season. Open Forum Infect Dis 2021;8:ofab167. [PMID: 34327253 DOI: 10.1093/ofid/ofab167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wagatsuma K, Saito R, Chon I, Phyu WW, Fujio K, Kawashima T, Sato I, Saito T, Minato M, Kodo N, Suzuki E, Ono Y, Masaki H, Shirahige Y, Kitano A, Hamabata H, Yuyang S, Jiaming L, Watanabe H. Duration of fever and symptoms in influenza-infected children treated with baloxavir marboxil during the 2019–2020 season in Japan and detection of influenza virus with the PA E23K substitution. Antiviral Research 2022;201:105310. [DOI: 10.1016/j.antiviral.2022.105310] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Qiu J, Wang H, Hu L, Yang C, Zhang T. Spatial transmission network construction of influenza-like illness using dynamic Bayesian network and vector-autoregressive moving average model. BMC Infect Dis 2021;21:164. [PMID: 33568082 DOI: 10.1186/s12879-021-05769-6] [Reference Citation Analysis]
4 Kempe A, Saville AW, Albertin C, Zimet G, Breck A, Helmkamp L, Vangala S, Dickinson LM, Rand C, Humiston S, Szilagyi PG. Parental Hesitancy About Routine Childhood and Influenza Vaccinations: A National Survey. Pediatrics 2020;146:e20193852. [PMID: 32540985 DOI: 10.1542/peds.2019-3852] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 28.5] [Reference Citation Analysis]
5 Patel A, Jernigan DB; 2019-nCoV CDC Response Team. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020. MMWR Morb Mortal Wkly Rep 2020;69:140-6. [PMID: 32027631 DOI: 10.15585/mmwr.mm6905e1] [Cited by in Crossref: 194] [Cited by in F6Publishing: 190] [Article Influence: 97.0] [Reference Citation Analysis]
6 Zhu R, Chen C, Wang Q, Zhang X, Lu C, Sun Y. Routine blood parameters are helpful for early identification of influenza infection in children. BMC Infect Dis 2020;20:864. [PMID: 33213395 DOI: 10.1186/s12879-020-05584-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hernández-García I, Giménez-Júlvez T. YouTube as a Source of Influenza Vaccine Information in Spanish. Int J Environ Res Public Health 2021;18:E727. [PMID: 33467755 DOI: 10.3390/ijerph18020727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Gallagher MC, Haessler S, Babcock HM. Influenza Vaccination and Healthcare Personnel Compliance. Curr Treat Options Infect Dis 2020;12:71-6. [PMID: 32435160 DOI: 10.1007/s40506-020-00211-y] [Reference Citation Analysis]
9 Cinicola B, Conti MG, Terrin G, Sgrulletti M, Elfeky R, Carsetti R, Fernandez Salinas A, Piano Mortari E, Brindisi G, De Curtis M, Zicari AM, Moschese V, Duse M. The Protective Role of Maternal Immunization in Early Life. Front Pediatr 2021;9:638871. [PMID: 33996688 DOI: 10.3389/fped.2021.638871] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Chung JR, Rolfes MA, Flannery B, Prasad P, O'Halloran A, Garg S, Fry AM, Singleton JA, Patel M, Reed C; US Influenza Vaccine Effectiveness Network, the Influenza Hospitalization Surveillance Network, and the Assessment Branch, Immunization Services Division, Centers for Disease Control and Prevention. Effects of Influenza Vaccination in the United States During the 2018-2019 Influenza Season. Clin Infect Dis 2020;71:e368-76. [PMID: 31905401 DOI: 10.1093/cid/ciz1244] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 25.0] [Reference Citation Analysis]
11 Tan MP, Tan WS, Mohamed Alitheen NB, Yap WB. M2e-Based Influenza Vaccines with Nucleoprotein: A Review. Vaccines (Basel) 2021;9:739. [PMID: 34358155 DOI: 10.3390/vaccines9070739] [Reference Citation Analysis]
12 Ferdinands JM, Gaglani M, Martin ET, Monto AS, Middleton D, Silveira F, Talbot HK, Zimmerman R, Patel M. Waning Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2015-2016 to 2018-2019, United States Hospitalized Adult Influenza Vaccine Effectiveness Network. Clin Infect Dis 2021;73:726-9. [PMID: 33462610 DOI: 10.1093/cid/ciab045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Diomidous M, Isaakidou M. Factors Influencing the Implementation of Flu Vaccination in Healthcare Professionals: Pros and Cons. Mater Sociomed 2020;32:307-14. [PMID: 33628135 DOI: 10.5455/msm.2020.32.307-314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Epperson S, Davis CT, Brammer L, Abd Elal AI, Ajayi N, Barnes J, Budd AP, Burns E, Daly P, Dugan VG, Fry AM, Jang Y, Johnson SJ, Kniss K, Kondor R, Grohskopf LA, Gubareva L, Merced-Morales A, Sessions W, Stevens J, Wentworth DE, Xu X, Jernigan D. Update: Influenza Activity - United States and Worldwide, May 19-September 28, 2019, and Composition of the 2020 Southern Hemisphere Influenza Vaccine. MMWR Morb Mortal Wkly Rep 2019;68:880-4. [PMID: 31600182 DOI: 10.15585/mmwr.mm6840a3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
15 Czaja CA, Cockburn MG, Colborn K, Miller L, Thomas DSK, Herlihy RK, Alden N, Simões EAF. Evaluation of rates of laboratory-confirmed influenza hospitalization in rural and urban census tracts over eight influenza seasons. Prev Med 2020;139:106184. [PMID: 32615128 DOI: 10.1016/j.ypmed.2020.106184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Sgrulletti M, Ottaviano G, Sangerardi M, Chini L, Dellepiane RM, Martire B, Montin D, Rizzo C, Moschese V. One step closer to influenza vaccine inclusiveness. Pediatr Allergy Immunol 2020;31 Suppl 26:69-71. [PMID: 33236432 DOI: 10.1111/pai.13338] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Syed H, Ascoli C, Linssen CF, Vagts C, Iden T, Syed A, Kron J, Polly K, Perkins D, Finn PW, Novak R, Drent M, Baughman R, Sweiss NJ. Infection prevention in sarcoidosis: proposal for vaccination and prophylactic therapy. Sarcoidosis Vasc Diffuse Lung Dis 2020;37:87-98. [PMID: 33093774 DOI: 10.36141/svdld.v37i2.9599] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Kang CK, Kim HR, Song KH, Keam B, Choi SJ, Choe PG, Kim ES, Kim NJ, Kim YJ, Park WB, Kim HB, Oh MD. Cell-Mediated Immunogenicity of Influenza Vaccination in Patients With Cancer Receiving Immune Checkpoint Inhibitors. J Infect Dis 2020;222:1902-9. [PMID: 32479600 DOI: 10.1093/infdis/jiaa291] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
19 Turner PJ, Fleming L, Saglani S, Southern J, Andrews NJ, Miller E; SNIFFLE-4 Study Investigators. Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma. J Allergy Clin Immunol 2020;145:1157-1164.e6. [PMID: 31863808 DOI: 10.1016/j.jaci.2019.12.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
20 Barbalho SM, Matias JN, Flato UAP, Pilon JPG, Bitelli P, Pagani Junior MA, de Carvalho ACA, Haber JFDS, Reis CHB, Goulart RA. What Do Influenza and COVID-19 Represent for Patients With Inflammatory Bowel Disease? Gastroenterology Res 2021;14:1-12. [PMID: 33737994 DOI: 10.14740/gr1358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Shinde V, Cai R, Plested J, Cho I, Fiske J, Pham X, Zhu M, Cloney-Clark S, Wang N, Zhou H, Zhou B, Patel N, Massare MJ, Fix A, Spindler M, Thomas DN, Smith G, Fries L, Glenn GM. Induction of Cross-reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-cell Responses by a Recombinant Matrix-M-Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine. Clin Infect Dis 2020:ciaa1673. [PMID: 33146720 DOI: 10.1093/cid/ciaa1673] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Sakala IG, Honda-Okubo Y, Li L, Baldwin J, Petrovsky N. A M2 protein-based universal influenza vaccine containing Advax-SM adjuvant provides newborn protection via maternal or neonatal immunization. Vaccine 2021;39:5162-72. [PMID: 34362601 DOI: 10.1016/j.vaccine.2021.07.037] [Reference Citation Analysis]
23 Sarti L, Lezmi G, Mori F, Giovannini M, Caubet JC. Diagnosis and management of hypersensitivity reactions to vaccines. Expert Rev Clin Immunol 2020;16:883-96. [PMID: 32838592 DOI: 10.1080/1744666X.2020.1814745] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Mathew NR, Angeletti D. Recombinant Influenza Vaccines: Saviors to Overcome Immunodominance. Front Immunol 2019;10:2997. [PMID: 31998299 DOI: 10.3389/fimmu.2019.02997] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
25 Le XTT, Nguyen HT, Le HT, Do TTT, Nguyen TH, Vu LG, Nguyen CT, Hoang MT, Tran BX, Latkin CA, Ho CSH, Ho RCM. Rural-urban differences in preferences for influenza vaccination among women of childbearing age: implications for local vaccination service implementation in Vietnam. Trop Med Int Health 2021;26:228-36. [PMID: 33164300 DOI: 10.1111/tmi.13515] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Belazi S, Olsen SJ, Brown C, Green HK, Mook P, Nguyen-Van-Tam J, Penttinen P, Lansbury L. Spotlight influenza: Laboratory-confirmed seasonal influenza in people with acute respiratory illness: a literature review and meta-analysis, WHO European Region, 2004 to 2017. Euro Surveill 2021;26. [PMID: 34596019 DOI: 10.2807/1560-7917.ES.2021.26.39.2000343] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Lucas JA, Marino M, Giebultowicz S, Fankhauser K, Suglia SF, Bailey SR, Bazemore A, Heintzman J. Mobility and social deprivation on primary care utilisation among paediatric patients with asthma. Fam Med Community Health 2021;9:e001085. [PMID: 34244305 DOI: 10.1136/fmch-2021-001085] [Reference Citation Analysis]
28 Treanor J. History of Live, Attenuated Influenza Vaccine. J Pediatric Infect Dis Soc 2020;9:S3-9. [PMID: 32191312 DOI: 10.1093/jpids/piz086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Okoli GN, Lam OLT, Abdulwahid T, Neilson CJ, Mahmud SM, Abou-Setta AM. Seasonal influenza vaccination among cancer patients: A systematic review and meta-analysis of the determinants. Curr Probl Cancer 2021;45:100646. [PMID: 32917396 DOI: 10.1016/j.currproblcancer.2020.100646] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Kennedy RB, Ovsyannikova IG, Poland GA. Update on Influenza Vaccines: Needs and Progress. J Allergy Clin Immunol Pract 2021;9:3599-603. [PMID: 34416408 DOI: 10.1016/j.jaip.2021.08.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Moro PL, Woo EJ, Marquez P, Cano M. Monitoring the safety of high-dose, trivalent inactivated influenza vaccine in the vaccine adverse event reporting system (VAERS), 2011 - 2019. Vaccine 2020;38:5923-6. [PMID: 32709434 DOI: 10.1016/j.vaccine.2020.07.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 De Sanctis V, Ruggiero L, Soliman AT, Daar S, Di Maio S, Kattamis C. Coronavirus Disease 2019 (COVID-19) in adolescents: An update on current clinical and diagnostic characteristics. Acta Biomed 2020;91:184-94. [PMID: 32420943 DOI: 10.23750/abm.v91i2.9543] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
33 Okoli GN, Rabbani R, Al-Juboori A, Copstein L, Askin N, Abou-Setta AM. Antiviral drugs for coronavirus disease 2019 (COVID-19): a systematic review with network meta-analysis. Expert Rev Anti Infect Ther 2021;:1-12. [PMID: 34323632 DOI: 10.1080/14787210.2021.1961579] [Reference Citation Analysis]
34 Tohiar MAH, Jaafar S, Aizuddin AN, Leong TK, Abdul Rahim AS. Workplace influenza vaccination in private hospital setting: a cost-benefit analysis. Ann Occup Environ Med 2022;34:e3. [DOI: 10.35371/aoem.2022.34.e3] [Reference Citation Analysis]
35 Tenforde MW, Talbot HK, Trabue CH, Gaglani M, McNeal TM, Monto AS, Martin ET, Zimmerman RK, Silveira FP, Middleton DB, Olson SM, Garten Kondor RJ, Barnes JR, Ferdinands JM, Patel MM; Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN) Investigators . Influenza Vaccine Effectiveness Against Hospitalization in the United States, 2019-2020. J Infect Dis 2021;224:813-20. [PMID: 33378531 DOI: 10.1093/infdis/jiaa800] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Lu PJ, Hung MC, Srivastav A, Grohskopf LA, Kobayashi M, Harris AM, Dooling KL, Markowitz LE, Rodriguez-Lainz A, Williams WW. Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018. MMWR Surveill Summ 2021;70:1-26. [PMID: 33983910 DOI: 10.15585/mmwr.ss7003a1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Sangesland M, Lingwood D. Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for 'Universal' Influenza Vaccines. Vaccines (Basel) 2021;9:125. [PMID: 33562627 DOI: 10.3390/vaccines9020125] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
38 Bazargan M, Wisseh C, Adinkrah E, Ameli H, Santana D, Cobb S, Assari S. Influenza Vaccination among Underserved African-American Older Adults. Biomed Res Int 2020;2020:2160894. [PMID: 33224975 DOI: 10.1155/2020/2160894] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
39 Kumar M, Iyer SS. ASSURED-SQVM diagnostics for COVID-19: addressing the why, when, where, who, what and how of testing. Expert Rev Mol Diagn 2021;21:349-62. [PMID: 33706663 DOI: 10.1080/14737159.2021.1902311] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Boikos C, Sylvester GC, Sampalis JS, Mansi JA. Relative Effectiveness of the Cell-Cultured Quadrivalent Influenza Vaccine Compared to Standard, Egg-derived Quadrivalent Influenza Vaccines in Preventing Influenza-like Illness in 2017-2018. Clin Infect Dis 2020;71:e665-71. [PMID: 32253431 DOI: 10.1093/cid/ciaa371] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
41 Patel A, Jernigan DB; 2019‐nCoV CDC Response Team. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak - United States, December 31, 2019-February 4, 2020. Am J Transplant 2020;20:889-95. [PMID: 32745377 DOI: 10.1111/ajt.15805] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 12.5] [Reference Citation Analysis]
42 Cardenas-Garcia S, Caceres CJ, Rajao D, Perez DR. Reverse genetics for influenza B viruses and recent advances in vaccine development. Curr Opin Virol 2020;44:191-202. [PMID: 33254031 DOI: 10.1016/j.coviro.2020.10.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
43 [DOI: 10.1101/2021.02.26.433142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Campbell AP, Ogokeh C, Weinberg GA, Boom JA, Englund JA, Williams JV, Halasa NB, Selvarangan R, Staat MA, Klein EJ, McNeal M, Michaels MG, Sahni LC, Stewart LS, Szilagyi PG, Harrison CJ, Lively JY, Rha B, Patel M. Effect of Vaccination on Preventing Influenza-Associated Hospitalizations Among Children During a Severe Season Associated with B/Victoria Viruses, 2019-2020. Clin Infect Dis 2021:ciab060. [PMID: 33502489 DOI: 10.1093/cid/ciab060] [Reference Citation Analysis]
45 Nypaver C, Dehlinger C, Carter C. Influenza and Influenza Vaccine: A Review. J Midwifery Womens Health 2021;66:45-53. [PMID: 33522695 DOI: 10.1111/jmwh.13203] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
46 Skarlupka AL, Handel A, Ross TM. Influenza hemagglutinin antigenic distance measures capture trends in HAI differences and infection outcomes, but are not suitable predictive tools. Vaccine 2020;38:5822-30. [PMID: 32682618 DOI: 10.1016/j.vaccine.2020.06.042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Okoli GN, Reddy VK, Al-Yousif Y, Neilson CJ, Mahmud SM, Abou-Setta AM. Sociodemographic and health-related determinants of seasonal influenza vaccination in pregnancy: A systematic review and meta-analysis of the evidence since 2000. Acta Obstet Gynecol Scand 2021;100:997-1009. [PMID: 33420724 DOI: 10.1111/aogs.14079] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Hernández-García I, Aibar-Remón C. Measures to Improve Influenza Vaccination Coverage in Spanish Medical Students. Vaccines (Basel) 2020;8:E238. [PMID: 32443718 DOI: 10.3390/vaccines8020238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 [DOI: 10.1101/2020.08.07.20170514] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Subbarao K. Live Attenuated Cold-Adapted Influenza Vaccines. Cold Spring Harb Perspect Med 2021;11:a038653. [PMID: 32253347 DOI: 10.1101/cshperspect.a038653] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
51 Caldera F, Ley D, Hayney MS, Farraye FA. Optimizing Immunization Strategies in Patients with IBD.Inflamm Bowel Dis. 2021;27:123-133. [PMID: 32232388 DOI: 10.1093/ibd/izaa055] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
52 Yildirim I, Kao CM, Tippett A, Suntarattiwong P, Munye M, Yi J, Elmontser M, Quincer E, Focht C, Watson N, Bilen H, Baker JM, Lopman B, Hogenesch E, Rostad CA, Anderson EJ. A Retrospective Test-Negative Case-Control Study to Evaluate Influenza Vaccine Effectiveness in Preventing Hospitalizations in Children. Clin Infect Dis 2021;73:1759-67. [PMID: 34410341 DOI: 10.1093/cid/ciab709] [Reference Citation Analysis]
53 Choi A, García-Sastre A, Schotsaert M. Host immune response-inspired development of the influenza vaccine. Ann Allergy Asthma Immunol 2020;125:28-35. [PMID: 32325117 DOI: 10.1016/j.anai.2020.04.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
54 Williams KV, Zhai B, Alcorn JF, Patricia Nowalk M, Levine MZ, Kim SS, Flannery B, Moehling Geffel K, Jaber Merranko A, Nagg JP, Collins M, Susick M, Clarke KS, Zimmerman RK, Martin JM. A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adults. Vaccine 2021:S0264-410X(21)01643-1. [PMID: 34952751 DOI: 10.1016/j.vaccine.2021.12.034] [Reference Citation Analysis]
55 Tylec A, Janiszewska M, Siejko K, Kucharska K. Determinants of the decision to be vaccinated against COVID-19 as exemplified by employees of a long-term health care centre. J Public Health (Oxf) 2021:fdab395. [PMID: 34929733 DOI: 10.1093/pubmed/fdab395] [Reference Citation Analysis]
56 Chiu SS, Chua H, Kwan MY, Chan EL, Wong JS, Peiris JM, Cowling BJ. Influenza vaccination effectiveness in preventing influenza hospitalization in children, Hong Kong, winter 2019/20. Vaccine 2020;38:8078-81. [DOI: 10.1016/j.vaccine.2020.10.081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Byron SC, Roth L, Acton RM, Shen A. Harnessing electronic clinical data to report adult and prenatal immunization quality measures. J Am Med Inform Assoc 2021:ocab125. [PMID: 34279653 DOI: 10.1093/jamia/ocab125] [Reference Citation Analysis]
58 Liu WC, Nachbagauer R, Stadlbauer D, Strohmeier S, Solórzano A, Berlanda-Scorza F, Innis BL, García-Sastre A, Palese P, Krammer F, Albrecht RA. Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model. Vaccines (Basel) 2021;9:40. [PMID: 33440898 DOI: 10.3390/vaccines9010040] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
59 Ojeda J, Arredondo JL, Salcedo P, Paredes-Paredes M, Dupuy M, Petit C, Chabanon AL, Rivas E, Gurunathan S, De Bruijn I, Pepin S. Immunogenicity and safety of a multi-dose quadrivalent inactivated influenza vaccine in individuals aged 6 months to 17 years: a randomized phase III trial. Hum Vaccin Immunother 2020;16:1380-4. [PMID: 31810418 DOI: 10.1080/21645515.2019.1697595] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Rioux M, McNeil M, Francis ME, Dawe N, Foley M, Langley JM, Kelvin AA. The Power of First Impressions: Can Influenza Imprinting during Infancy Inform Vaccine Design? Vaccines (Basel) 2020;8:E546. [PMID: 32961707 DOI: 10.3390/vaccines8030546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Wang Y, Deng L, Gonzalez GX, Luthra L, Dong C, Ma Y, Zou J, Kang SM, Wang BZ. Double-Layered M2e-NA Protein Nanoparticle Immunization Induces Broad Cross-Protection against Different Influenza Viruses in Mice. Adv Healthc Mater 2020;9:e1901176. [PMID: 31840437 DOI: 10.1002/adhm.201901176] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
62 Izurieta HS, Chillarige Y, Kelman J, Wei Y, Lu Y, Xu W, Lu M, Pratt D, Wernecke M, MaCurdy T, Forshee R. Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018-2019. J Infect Dis 2020;222:278-87. [PMID: 32100009 DOI: 10.1093/infdis/jiaa080] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 20.0] [Reference Citation Analysis]
63 Guidry JPD, Austin LL, O'Donnell NH, Coman IA, Lovari A, Messner M. Tweeting the #flushot: Beliefs, Barriers, and Threats During Different Periods of the 2018 to 2019 Flu Season. J Prim Care Community Health 2020;11:2150132720932722. [PMID: 33089738 DOI: 10.1177/2150132720932722] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
64 Batarseh YS, Darwish Elhajji FW, Shammas S, Darwish RM, Fakhoury R, Al Haj Ahmad M, Al Rusasi A, Jarrar L. Perception and attitude of the public on vaccine practices and pharmacists as immunizers in Jordan. Journal of Pharmaceutical Health Services Research 2021;12:114-21. [DOI: 10.1093/jphsr/rmaa009] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Gao R, Sheng Z, Sreenivasan CC, Wang D, Li F. Influenza A Virus Antibodies with Antibody-Dependent Cellular Cytotoxicity Function. Viruses 2020;12:E276. [PMID: 32121563 DOI: 10.3390/v12030276] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
66 Alawneh I, Al-sayeh H, Zaid M, Alawneh M, Al-tatari H, Burns CJ. Knowledge and Attitudes Regarding Seasonal Influenza and Influenza Vaccination among Patients and Their Companions in North Palestine Hospitals. Advances in Public Health 2021;2021:1-5. [DOI: 10.1155/2021/3611846] [Reference Citation Analysis]
67 Williams VR, McGuire M, Katz K, Leis JA. Minimum healthcare worker influenza immunization rates required to decrease influenza transmission in two acute-care hospitals. Infect Control Hosp Epidemiol 2021;42:109-10. [PMID: 33109283 DOI: 10.1017/ice.2020.1252] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Shannon I, White CL, Yang H, Nayak JL. Differences in Influenza-Specific CD4 T-Cell Mediated Immunity Following Acute Infection Versus Inactivated Vaccination in Children. J Infect Dis 2021;223:2164-73. [PMID: 33074330 DOI: 10.1093/infdis/jiaa664] [Reference Citation Analysis]
69 Sun Y, Yang P, Wang Q, Zhang L, Duan W, Pan Y, Wu S, Wang H. Influenza Vaccination and Non-Pharmaceutical Measure Effectiveness for Preventing Influenza Outbreaks in Schools: A Surveillance-Based Evaluation in Beijing. Vaccines (Basel) 2020;8:E714. [PMID: 33271800 DOI: 10.3390/vaccines8040714] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Ogokeh CE, Campbell AP, Feldstein LR, Weinberg GA, Staat MA, McNeal MM, Selvarangan R, Halasa NB, Englund JA, Boom JA, Azimi PH, Szilagyi PG, Harrison CJ, Williams JV, Klein EJ, Stewart LS, Sahni LC, Singer MN, Lively JY, Payne DC, Patel M; New Vaccine Surveillance Network. Comparison of Parental Report of Influenza Vaccination to Documented Records in Children Hospitalized With Acute Respiratory Illness, 2015-2016. J Pediatric Infect Dis Soc 2021;10:389-97. [PMID: 33043965 DOI: 10.1093/jpids/piaa110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Jones JL, Tse F, Carroll MW, deBruyn JC, McNeil SA, Pham-Huy A, Seow CH, Barrett LL, Bessissow T, Carman N, Melmed GY, Vanderkooi OG, Marshall JK, Benchimol EI. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines. Gastroenterology 2021;161:681-700. [PMID: 34334167 DOI: 10.1053/j.gastro.2021.04.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Lu L, Fong CH, Zhang AJ, Wu WL, Li IC, Lee AC, Dissanayake TK, Chen L, Hung IF, Chan KH, Chu H, Kok KH, Yuen KY, To KK. Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine. Vaccines (Basel) 2020;8:E754. [PMID: 33322574 DOI: 10.3390/vaccines8040754] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
73 Chang YC, Tung HJ, Huang YT, Lu CT, Ernawaty E, Wu SY. Effect of Influenza Vaccination on Mortality and Risk of Hospitalization in Elderly Individuals with and without Disabilities: A Nationwide, Population-Based Cohort Study. Vaccines (Basel) 2020;8:E112. [PMID: 32121645 DOI: 10.3390/vaccines8010112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
74 Bolge SC, Gutierrez C, Kariburyo F, He D. Burden of Pneumonia Among Hospitalized Patients with Influenza: Real-World Evidence from a US Managed Care Population. Pulm Ther 2021. [PMID: 34398424 DOI: 10.1007/s41030-021-00169-2] [Reference Citation Analysis]
75 Keam B, Kang CK, Jun KI, Moon SM, Suh KJ, Lee D, Ock C, Kim M, Choi Y, Lim Y, Lee K, Kim SH, Kim TM, Kim T, Oh D, Kim D, Im S, Lee JS, Kim ES, Kim HB, Kim N, Kim YJ, Park WB, Oh M. Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint Inhibitors. Clinical Infectious Diseases 2020;71:422-5. [DOI: 10.1093/cid/ciz1092] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
76 Mahmood A, Kim H, Kabir U, Kedia S, Ray M. Food Insecurity and Influenza and Pneumonia Vaccines Uptake Among Community-Dwelling Older Adults in the United States. J Community Health 2020;45:943-53. [PMID: 32219711 DOI: 10.1007/s10900-020-00812-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
77 Jacobson RM. Routine Childhood Vaccines Given From 1 through 18 Years of Age. Mayo Clin Proc 2020;95:1780-95. [PMID: 32753151 DOI: 10.1016/j.mayocp.2020.06.004] [Reference Citation Analysis]
78 Moons P, Fieuws S, Vandermeulen C, Ombelet F, Willems R, Goossens E, Van Bulck L, de Hosson M, Annemans L, Budts W, De Backer J, Moniotte S, Marelli A, De Groote K; BELCODAC Consortium. Influenza Vaccination in Patients With Congenital Heart Disease in the Pre-COVID-19 Era: Coverage Rate, Patient Characteristics, and Outcomes. Can J Cardiol 2021:S0828-282X(21)00216-6. [PMID: 33961983 DOI: 10.1016/j.cjca.2021.04.010] [Reference Citation Analysis]
79 Nayak J, Hoy G, Gordon A. Influenza in Children. Cold Spring Harb Perspect Med 2021;11:a038430. [PMID: 31871228 DOI: 10.1101/cshperspect.a038430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
80 Owusu D, Hand J, Tenforde MW, Feldstein LR, Dasilva J, Barnes J, Lee G, Tran J, Sokol T, Fry AM, Brammer L, Rolfes MA. Early season pediatric influenza B/Victoria virus infections associated with a recently emerged virus subclade — Louisiana, 2019. Am J Transplant 2019;20:606-9. [DOI: 10.1111/ajt.15782] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Daley MF, Reifler LM, Shoup JA, Glanz JM, Naleway AL, Jackson ML, Hambidge SJ, Mclean H, Kharbanda EO, Klein NP, Lewin BJ, Weintraub ES, Mcneil MM, Razzaghi H, Singleton JA. Influenza Vaccination Among Pregnant Women: Self-report Compared With Vaccination Data From Electronic Health Records, 2018-2020 Influenza Seasons. Public Health Rep. [DOI: 10.1177/00333549221099932] [Reference Citation Analysis]
82 Toth JM, Nsiah I, Nair S, Ramachandran S. Association between a usual source of care and influenza vaccination rates among pregnant women. Pharmacoepidemiol Drug Saf 2021. [PMID: 34888983 DOI: 10.1002/pds.5394] [Reference Citation Analysis]
83 Conlon A, Ashur C, Washer L, Eagle KA, Hofmann Bowman MA. Impact of the influenza vaccine on COVID-19 infection rates and severity. Am J Infect Control 2021;49:694-700. [PMID: 33631305 DOI: 10.1016/j.ajic.2021.02.012] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 48.0] [Reference Citation Analysis]
84 Boikos C, Fischer L, O'Brien D, Vasey J, Sylvester GC, Mansi JA. Relative Effectiveness of the Cell-derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-related Medical Encounters During the 2018-2019 Influenza Season in the United States. Clin Infect Dis 2021;73:e692-8. [PMID: 33400775 DOI: 10.1093/cid/ciaa1944] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
85 Cardenas-Garcia S, Cáceres CJ, Jain A, Geiger G, Mo JS, Jasinskas A, Nakajima R, Rajao DS, Davies DH, Perez DR. FluB-RAM and FluB-RANS: Genome Rearrangement as Safe and Efficacious Live Attenuated Influenza B Virus Vaccines. Vaccines (Basel) 2021;9:897. [PMID: 34452022 DOI: 10.3390/vaccines9080897] [Reference Citation Analysis]
86 Niang MN, Sugimoto JD, Diallo A, Diarra B, Ortiz JR, Lewis KDC, Lafond KE, Halloran ME, Widdowson MA, Neuzil KM, Victor JC. Estimates of Inactivated Influenza Vaccine Effectiveness Among Children in Senegal: Results From 2 Consecutive Cluster-Randomized Controlled Trials in 2010 and 2011. Clin Infect Dis 2021;72:e959-69. [PMID: 33165566 DOI: 10.1093/cid/ciaa1689] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Johnson J, Akinboyo IC, Schaffzin JK. Infection Prevention in the Neonatal Intensive Care Unit. Clin Perinatol 2021;48:413-29. [PMID: 34030822 DOI: 10.1016/j.clp.2021.03.011] [Reference Citation Analysis]
88 Zheng B, Peng W, Guo M, Huang M, Gu Y, Wang T, Ni G, Ming D. Inhalable nanovaccine with biomimetic coronavirus structure to trigger mucosal immunity of respiratory tract against COVID-19. Chem Eng J 2021;418:129392. [PMID: 33762883 DOI: 10.1016/j.cej.2021.129392] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
89 Verstraeten T, Fletcher MA, Suaya JA, Jackson S, Hall-Murray CK, Scott DA, Schmöle-Thoma B, Isturiz RE, Gessner BD. Diabetes mellitus as a vaccine-effect modifier: a review. Expert Rev Vaccines 2020;19:445-53. [PMID: 32516066 DOI: 10.1080/14760584.2020.1760098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
90 Nyasimi FM, Owuor DC, Ngoi JM, Mwihuri AG, Otieno GP, Otieno JR, Githinji G, Nyiro JU, Nokes DJ, Agoti CN. Epidemiological and evolutionary dynamics of influenza B virus in coastal Kenya as revealed by genomic analysis of strains sampled over a single season. Virus Evol 2020;6:veaa045. [PMID: 33747542 DOI: 10.1093/ve/veaa045] [Reference Citation Analysis]
91 Weinberg GA. Live, Attenuated Influenza Vaccine: Present and Future Roles. Journal of the Pediatric Infectious Diseases Society 2020;9:S1-2. [DOI: 10.1093/jpids/piz100] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Mettelman RC, Thomas PG. Human Susceptibility to Influenza Infection and Severe Disease. Cold Spring Harb Perspect Med 2021;11:a038711. [PMID: 31964647 DOI: 10.1101/cshperspect.a038711] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
93 Owusu D, Hand J, Tenforde MW, Feldstein LR, DaSilva J, Barnes J, Lee G, Tran J, Sokol T, Fry AM, Brammer L, Rolfes MA. Early Season Pediatric Influenza B/Victoria Virus Infections Associated with a Recently Emerged Virus Subclade - Louisiana, 2019. MMWR Morb Mortal Wkly Rep 2020;69:40-3. [PMID: 31945035 DOI: 10.15585/mmwr.mm6902e1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
94 Grijalva CG, Feldstein LR, Talbot HK, Aboodi M, Baughman AH, Brown SM, Casey JD, Erickson HL, Exline MC, Files DC, Gibbs KW, Ginde AA, Gong MN, Halasa N, Khan A, Lindsell CJ, Nwosu SK, Peltan ID, Prekker ME, Rice TW, Shapiro NI, Steingrub J, Stubblefield WB, Tenforde MW, Patel M, Self WH; Influenza and Other Viruses in the Acutely Ill (IVY) Network. Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness among Adults in the United States, 2019-2020: A test-negative study. Clin Infect Dis 2021:ciab462. [PMID: 34014274 DOI: 10.1093/cid/ciab462] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
95 Niang M, Deming ME, Goudiaby D, Diop OM, Dia N, Diallo A, Ortiz JR, Diop D, Lewis KDC, Lafond KE, Widdowson MA, Victor JC, Neuzil KM. Immunogenicity of seasonal inactivated influenza and inactivated polio vaccines among children in Senegal: Results from a cluster-randomized trial. Vaccine 2020;38:7526-32. [PMID: 33012603 DOI: 10.1016/j.vaccine.2020.09.059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
96 Kalligeros M, Shehadeh F, Mylona EK, Dapaah-Afriyie C, van Aalst R, Chit A, Mylonakis E. Influenza vaccine effectiveness against influenza-associated hospitalization in children: A systematic review and meta-analysis. Vaccine 2020;38:2893-903. [PMID: 32113808 DOI: 10.1016/j.vaccine.2020.02.049] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
97 Yoshino Y, Wakabayashi Y, Kitazawa T. The Clinical Effect of Seasonal Flu Vaccination on Health-Related Quality of Life. Int J Gen Med 2021;14:2095-9. [PMID: 34079350 DOI: 10.2147/IJGM.S309920] [Reference Citation Analysis]
98 Cowling BJ, Thompson MG, Ng TWY, Fang VJ, Perera RAPM, Leung NHL, Chen Y, So HC, Ip DKM, Iuliano AD. Comparative Reactogenicity of Enhanced Influenza Vaccines in Older Adults. J Infect Dis 2020;222:1383-91. [PMID: 32407535 DOI: 10.1093/infdis/jiaa255] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
99 Mohme S, Schmalzing M, Müller CSL, Vogt T, Goebeler M, Stoevesandt J. Immunizations in immunocompromised patients: a guide for dermatologists. J Dtsch Dermatol Ges 2020;18:699-723. [PMID: 32713146 DOI: 10.1111/ddg.14156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
100 Izurieta HS, Lu M, Kelman J, Lu Y, Lindaas A, Loc J, Pratt D, Wei Y, Chillarige Y, Wernecke M, MaCurdy TE, Forshee R. Comparative effectiveness of influenza vaccines among U.S. Medicare beneficiaries ages 65 years and older during the 2019-20 season. Clin Infect Dis 2020:ciaa1727. [PMID: 33211809 DOI: 10.1093/cid/ciaa1727] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
101 Chen CJ, Stanciu AC. Simulating influenza epidemics with waning vaccine immunity. Medicine (Baltimore) 2021;100:e27169. [PMID: 34516511 DOI: 10.1097/MD.0000000000027169] [Reference Citation Analysis]
102 Tenforde MW, Kondor RJG, Chung JR, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Rao A, Kim SS, Stark TJ, Barnes JR, Wentworth D, Patel MM, Flannery B. Effect of antigenic drift on influenza vaccine effectiveness in the United States - 2019-2020. Clin Infect Dis 2020:ciaa1884. [PMID: 33367650 DOI: 10.1093/cid/ciaa1884] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
103 Guillari A, Polito F, Pucciarelli G, Serra N, Gargiulo G, Esposito MR, Botti S, Rea T, Simeone S. Influenza vaccination and healthcare workers: barriers and predisposing factors. Acta Biomed 2021;92:e2021004. [PMID: 33855983 DOI: 10.23750/abm.v92iS2.11106] [Reference Citation Analysis]
104 Shinde V, Cho I, Plested JS, Agrawal S, Fiske J, Cai R, Zhou H, Pham X, Zhu M, Cloney-Clark S, Wang N, Zhou B, Lewis M, Price-Abbott P, Patel N, Massare MJ, Smith G, Keech C, Fries L, Glenn GM. Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trial. Lancet Infect Dis 2021:S1473-3099(21)00192-4. [PMID: 34563277 DOI: 10.1016/S1473-3099(21)00192-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Enwemeka CS, Baker TL, Bumah VV. The role of UV and blue light in photo-eradication of microorganisms. Journal of Photochemistry and Photobiology 2021;8:100064. [DOI: 10.1016/j.jpap.2021.100064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
106 de Perio MA, Kobayashi M, Wortham JM. Occupational Respiratory Infections. Clin Chest Med 2020;41:739-51. [PMID: 33153691 DOI: 10.1016/j.ccm.2020.08.003] [Reference Citation Analysis]
107 Dawood FS, Chung JR, Kim SS, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Dunnigan K, Foust A, Sessions W, DaSilva J, Le S, Stark T, Kondor RJ, Barnes JR, Wentworth DE, Brammer L, Fry AM, Patel MM, Flannery B. Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020. MMWR Morb Mortal Wkly Rep 2020;69:177-82. [PMID: 32078591 DOI: 10.15585/mmwr.mm6907a1] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 27.5] [Reference Citation Analysis]
108 de Armas LR, George V, Filali-Mouhim A, Steel C, Parmigiani A, Cunningham CK, Weinberg A, Trautmann L, Sekaly RP, Cameron MJ, Pahwa S. Transcriptional and Immunologic Correlates of Response to Pandemic Influenza Vaccine in Aviremic, HIV-Infected Children. Front Immunol 2021;12:639358. [PMID: 33868267 DOI: 10.3389/fimmu.2021.639358] [Reference Citation Analysis]
109 Behrouzi B, Udell JA. Moving the Needle on Atherosclerotic Cardiovascular Disease and Heart Failure with Influenza Vaccination. Curr Atheroscler Rep 2021;23:78. [PMID: 34671861 DOI: 10.1007/s11883-021-00973-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 MacDonald SE, Palichuk A, Slater L, Tripp H, Reifferscheid L, Burton C. Gaps in knowledge about the vaccine coverage of immunocompromised children: a scoping review. Hum Vaccin Immunother 2021;:1-16. [PMID: 34270376 DOI: 10.1080/21645515.2021.1935169] [Reference Citation Analysis]
111 Feldstein LR, Ogokeh C, Rha B, Weinberg GA, Staat MA, Selvarangan R, Halasa NB, Englund JA, Boom JA, Azimi PH, Szilagyi PG, McNeal M, Harrison CJ, Williams JV, Klein EJ, Sahni LC, Singer MN, Lively JY, Payne DC, Fry AM, Patel M, Campbell AP. Vaccine Effectiveness Against Influenza Hospitalization Among Children in the United States, 2015-2016. J Pediatric Infect Dis Soc 2021;10:75-82. [PMID: 32108879 DOI: 10.1093/jpids/piaa017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
112 Naleway AL, Crane B, Irving SA, Bachman D, Vesco KK, Daley MF, Getahun D, Glenn SC, Hambidge SJ, Jackson LA, Klein NP, McCarthy NL, McClure DL, Panagiotakopoulos L, Panozzo CA, Vazquez-Benitez G, Weintraub ES, Zerbo O, Kharbanda EO. Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination. Ther Adv Drug Saf 2021;12:20420986211021233. [PMID: 34178302 DOI: 10.1177/20420986211021233] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
113 Chang YC, Yu-Tung H, Chen LS, Tung HJ, Huang KH, Ernawaty E, Wu SY. Protective Effect of Seasonal Influenza Vaccination in Elderly Individuals with Disability in Taiwan: A Propensity Score-Matched, Nationwide, Population-Based Cohort Study. Vaccines (Basel) 2020;8:E140. [PMID: 32235779 DOI: 10.3390/vaccines8010140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
114 Grohskopf LA, Alyanak E, Broder KR, Blanton LH, Fry AM, Jernigan DB, Atmar RL. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season. MMWR Recomm Rep 2020;69:1-24. [PMID: 32820746 DOI: 10.15585/mmwr.rr6908a1] [Cited by in Crossref: 72] [Cited by in F6Publishing: 78] [Article Influence: 36.0] [Reference Citation Analysis]
115 Caffrey AR, Borrelli EP. The art and science of drug titration. Ther Adv Drug Saf 2020;11:2042098620958910. [PMID: 33796256 DOI: 10.1177/2042098620958910] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
116 Findley PA, Wiener RC, Shen C, Dwibedi N, Sambamoorthi U. Clinical Preventive Services and Self-Management Practices Among Adult Cancer Survivors in the United States Over Time. Cancer Control 2021;28:10732748211059106. [PMID: 34823385 DOI: 10.1177/10732748211059106] [Reference Citation Analysis]
117 Sakuraba A, Luna A, Micic D. Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis. J Hematol Oncol 2022;15. [DOI: 10.1186/s13045-022-01233-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
118 Manneh B, Andrew MK, Okechukwu CE. Life Satisfaction and Influenza Vaccination Among Older Adults in Canada. Can J Aging 2022;:1-9. [PMID: 35899995 DOI: 10.1017/S0714980822000204] [Reference Citation Analysis]
119 Jones JL, Tse F, Carroll MW, deBruyn JC, McNeil SA, Pham-Huy A, Seow CH, Barrett LL, Bessissow T, Carman N, Melmed GY, Vanderkooi OG, Marshall JK, Benchimol EI. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines. J Can Assoc Gastroenterol 2021;4:e72-91. [PMID: 34476339 DOI: 10.1093/jcag/gwab016] [Reference Citation Analysis]
120 Javanian M, Barary M, Ghebrehewet S, Koppolu V, Vasigala V, Ebrahimpour S. A brief review of influenza virus infection. J Med Virol 2021;93:4638-46. [PMID: 33792930 DOI: 10.1002/jmv.26990] [Reference Citation Analysis]
121 Ueberroth BE, Labonte HR, Wallace MR. Impact of Patient Portal Messaging Reminders with Self-Scheduling Option on Influenza Vaccination Rates: a Prospective, Randomized Trial. J Gen Intern Med 2021. [PMID: 34131878 DOI: 10.1007/s11606-021-06941-z] [Reference Citation Analysis]
122 Sibanda M, Meyer JC, Mahlaba KJ, Burnett RJ. Promoting Healthy Ageing in South Africa Through Vaccination of the Elderly. Front Public Health 2021;9:635266. [PMID: 33981664 DOI: 10.3389/fpubh.2021.635266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
123 Gaglani M, Flannery B. Reply to Yager and Doll. Clin Infect Dis 2020;71:3264-5. [PMID: 32202294 DOI: 10.1093/cid/ciaa311] [Reference Citation Analysis]
124 Jarvis JR, Dorey RB, Warricker FDM, Alwan NA, Jones CE. The effectiveness of influenza vaccination in pregnancy in relation to child health outcomes: Systematic review and meta-analysis. Vaccine 2020;38:1601-13. [PMID: 31932138 DOI: 10.1016/j.vaccine.2019.12.056] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
125 Heintzman J, Kaufmann J, Bailey S, Lucas J, Suglia SF, Puro J, Giebultowicz S, Ezekiel-Herrera D, Marino M. Asthma Ambulatory Care Quality in Foreign-Born Latino Children in the United States. Acad Pediatr 2022;22:647-56. [PMID: 34688905 DOI: 10.1016/j.acap.2021.10.003] [Reference Citation Analysis]
126 Shanko A, Shuklina M, Kovaleva A, Zabrodskaya Y, Vidyaeva I, Shaldzhyan A, Fadeev A, Korotkov A, Zaitceva M, Stepanova L, Tsybalova L, Kordyukova L, Katlinski A. Comparative Immunological Study in Mice of Inactivated Influenza Vaccines Used in the Russian Immunization Program. Vaccines (Basel) 2020;8:E756. [PMID: 33322762 DOI: 10.3390/vaccines8040756] [Reference Citation Analysis]
127 Tillard C, Chazard E, Faure K, Bartolo S, Martinot A, Dubos F. Burden of influenza disease in children under 2 years of age hospitalized between 2011 and 2020 in France. J Infect 2021:S0163-4453(21)00549-1. [PMID: 34785266 DOI: 10.1016/j.jinf.2021.11.006] [Reference Citation Analysis]
128 Lippert JF, Buscemi J, Saiyed N, Silva A, Benjamins MR. Influenza and Pneumonia Mortality Across the 30 Biggest U.S. Cities: Assessment of Overall Trends and Racial Inequities. J Racial Ethn Health Disparities 2021. [PMID: 34008148 DOI: 10.1007/s40615-021-01056-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 Schieber A, O'Gurek D. Vaccinating in Pregnancy: Opportunities and Challenges. Prim Care 2020;47:443-52. [PMID: 32718442 DOI: 10.1016/j.pop.2020.05.001] [Reference Citation Analysis]
130 Robinson CL, Bernstein H, Poehling K, Romero JR, Szilagyi P. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2020. MMWR Morb Mortal Wkly Rep 2020;69:130-2. [PMID: 32027628 DOI: 10.15585/mmwr.mm6905a3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
131 Ferdinands JM, Gaglani M, Ghamande S, Martin ET, Middleton D, Monto AS, Silveira F, Talbot HK, Zimmerman R, Smith ER, Patel M; US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN) Study Investigators. Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network. J Infect Dis 2021;224:151-63. [PMID: 33336702 DOI: 10.1093/infdis/jiaa772] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
132 George LL, Malik MN, Miller EJ, Hicks K, Khanam R, Saterehaseman A, McNichol M, Anwer F. Special Considerations for Supportive Care and Management of Complications in Elderly Patients With Multiple Myeloma. Clin Lymphoma Myeloma Leuk 2021:S2152-2650(21)00284-6. [PMID: 34384735 DOI: 10.1016/j.clml.2021.07.013] [Reference Citation Analysis]
133 Boikos C, Imran M, Nguyen VH, Ducruet T, Sylvester GC, Mansi JA. Effectiveness of the Adjuvanted Influenza Vaccine in Older Adults at High Risk of Influenza Complications. Vaccines (Basel) 2021;9:862. [PMID: 34451987 DOI: 10.3390/vaccines9080862] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Rao S, Moss A, Lamb MM, Asturias EJ. Evaluation of Influenza Vaccine Effectiveness Among Young Children Receiving Consecutive Versus Nonconsecutive Vaccination During Influenza A(H3N2)-Predominant Seasons. J Pediatric Infect Dis Soc 2021;10:359-62. [PMID: 32756876 DOI: 10.1093/jpids/piaa080] [Reference Citation Analysis]
135 Krishnarajah G, Divino V, Postma MJ, Pelton SI, Anupindi VR, DeKoven M, Mould-Quevedo J. Clinical and Economic Outcomes Associated with Cell-Based Quadrivalent Influenza Vaccine vs. Standard-Dose Egg-Based Quadrivalent Influenza Vaccines during the 2018-19 Influenza Season in the United States. Vaccines (Basel) 2021;9:80. [PMID: 33498724 DOI: 10.3390/vaccines9020080] [Reference Citation Analysis]
136 Bardenheier BH, Baier RR, Silva JB, Gravenstein S, Moyo P, Bosco E, Ogarek J, van Aalst R, Chit A, Zullo AR. Persistence of Racial Inequities in Receipt of Influenza Vaccination among Nursing Home Residents in the United States. Clin Infect Dis 2020:ciaa1484. [PMID: 32990309 DOI: 10.1093/cid/ciaa1484] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
137 Chaudhry SN, Hazafa A, Mumtaz M, Kalsoom U, Abbas S, Kainaat A, Bilal S, Zafar N, Siddique A, Zafar A. New insights on possible vaccine development against SARS-CoV-2. Life Sci 2020;260:118421. [PMID: 32926920 DOI: 10.1016/j.lfs.2020.118421] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
138 Freedman MS, Hunter P, Ault K, Kroger A. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older - United States, 2020. MMWR Morb Mortal Wkly Rep 2020;69:133-5. [PMID: 32027627 DOI: 10.15585/mmwr.mm6905a4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
139 L'huillier AG, Ferreira VH, Hirzel C, Natori Y, Slomovic J, Ku T, Hoschler K, Ierullo M, Selzner N, Schiff J, Singer LG, Humar A, Kumar D. Cell-Mediated Immune Responses After Influenza Vaccination of Solid Organ Transplant Recipients: Secondary Outcomes Analyses of a Randomized Controlled Trial. J Infect Dis 2020;221:53-62. [PMID: 31550354 DOI: 10.1093/infdis/jiz471] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
140 Prasad N, Trenholme AA, Huang QS, Duque J, Grant CC, Newbern EC. Respiratory Virus-related Emergency Department Visits and Hospitalizations Among Infants in New Zealand. Pediatr Infect Dis J 2020;39:e176-82. [PMID: 32675757 DOI: 10.1097/INF.0000000000002681] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
141 Hall LL, Xu L, Mahmud SM, Puckrein GA, Thommes EW, Chit A. A Map of Racial and Ethnic Disparities in Influenza Vaccine Uptake in the Medicare Fee-for-Service Program. Adv Ther 2020;37:2224-35. [PMID: 32274750 DOI: 10.1007/s12325-020-01324-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 9.5] [Reference Citation Analysis]
142 Jędrzejek MJ, Mastalerz-migas A. Influenza Vaccination Coverage, Motivators for, and Barriers to Influenza Vaccination among Healthcare Workers in Wroclaw, Poland. IJERPH 2022;19:1586. [DOI: 10.3390/ijerph19031586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 Moore D, Gemmill I, Harrison R. Summary of the NACI systematic review and recommendation on the use of live attenuated influenza vaccine (LAIV) in HIV-infected individuals. Can Commun Dis Rep 2020;46:299-304. [PMID: 33104088 DOI: 10.14745/ccdr.v46i09a08] [Reference Citation Analysis]
144 Madewell ZJ, Chacón-Fuentes R, Jara J, Mejía-Santos H, Molina IB, Alvis-Estrada JP, Ortiz MR, Coello-Licona R, Montejo B. Knowledge, attitudes, and practices of seasonal influenza vaccination in healthcare workers, Honduras. PLoS One 2021;16:e0246379. [PMID: 33539428 DOI: 10.1371/journal.pone.0246379] [Reference Citation Analysis]
145 Grandhi GR, Mszar R, Vahidy F, Valero-Elizondo J, Blankstein R, Blaha MJ, Virani SS, Andrieni JD, Omer SB, Nasir K. Sociodemographic Disparities in Influenza Vaccination Among Adults With Atherosclerotic Cardiovascular Disease in the United States. JAMA Cardiol 2021;6:87-91. [PMID: 32902562 DOI: 10.1001/jamacardio.2020.3978] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
146 Colucci ME, Affanni P, Cantarelli A, Caruso L, Bracchi MT, Capobianco E, Zoni R, Paini G, Odone A, Mohieldin Mahgoub Ibrahim MM, Veronesi L. Influenza vaccine effectiveness in children: a retrospective study on eight post-pandemic seasons with trivalent inactivated vaccine. Acta Biomed 2020;91:63-70. [PMID: 32275269 DOI: 10.23750/abm.v91i3-S.9424] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
147 Czaja CA, Cockburn MG, Colborn K, Miller L, Thomas DSK, Herlihy RK, Alden N, Simões EAF. Adult Population Coverage With Influenza Vaccine and Influenza Hospitalization Rates-Is There a Role for Active Outreach to Immunize At-Risk Neighborhoods? Clin Infect Dis 2021;73:1110-2. [PMID: 33714995 DOI: 10.1093/cid/ciab231] [Reference Citation Analysis]
148 Löwensteyn YN, Nair H, Nunes MC, van Roessel I, Vernooij FS, Willemsen J, Bont LJ, Mazur NI; FLU GOLD study group. Estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: A retrospective case series. EClinicalMedicine 2021;37:100945. [PMID: 34386739 DOI: 10.1016/j.eclinm.2021.100945] [Reference Citation Analysis]
149 Riester MR, Bosco E, Bardenheier BH, Moyo P, Baier RR, Eliot M, Silva JB, Gravenstein S, van Aalst R, Chit A, Loiacono MM, Zullo AR. Decomposing Racial and Ethnic Disparities in Nursing Home Influenza Vaccination. J Am Med Dir Assoc 2021;22:1271-1278.e3. [PMID: 33838115 DOI: 10.1016/j.jamda.2021.03.003] [Reference Citation Analysis]
150 Chahine EB. High-Dose Inactivated Influenza Vaccine Quadrivalent for Older Adults. Ann Pharmacother 2021;55:89-97. [PMID: 32578447 DOI: 10.1177/1060028020935645] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
151 Adams JC, Biswas HH, Boulet SL, Doraivelu K, Saums MK, Haddad L, Jamieson DJ. Factors Associated with Antenatal Influenza Vaccination in a Medically Underserved Population. Infect Dis Obstet Gynecol 2020;2020:5803926. [PMID: 32410818 DOI: 10.1155/2020/5803926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
152 Abu-Raya B, Maertens K, Edwards KM, Omer SB, Englund JA, Flanagan KL, Snape MD, Amirthalingam G, Leuridan E, Damme PV, Papaevangelou V, Launay O, Dagan R, Campins M, Cavaliere AF, Frusca T, Guidi S, O'Ryan M, Heininger U, Tan T, Alsuwaidi AR, Safadi MA, Vilca LM, Wanlapakorn N, Madhi SA, Giles ML, Prymula R, Ladhani S, Martinón-Torres F, Tan L, Michelin L, Scambia G, Principi N, Esposito S. Global Perspectives on Immunization During Pregnancy and Priorities for Future Research and Development: An International Consensus Statement. Front Immunol 2020;11:1282. [PMID: 32670282 DOI: 10.3389/fimmu.2020.01282] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 10.5] [Reference Citation Analysis]
153 Parente DJ, Murray MJ, Woodward J. Association Between Unmet Essential Social Needs and Influenza Vaccination in US Adults. J Gen Intern Med 2021. [PMID: 34131879 DOI: 10.1007/s11606-021-06902-6] [Reference Citation Analysis]
154 Grandhi GR, Mozafarian M, Mszar R, Acquah I, Valero-Elizondo J, Cainzos-Achirica M, Omer SB, Ibrahim HN, Nasir K. Influenza Vaccination Among Adults With CKD in the United States: Regional, Demographic, and Socioeconomic Differences. Kidney Med 2021;3:454-6. [PMID: 34136792 DOI: 10.1016/j.xkme.2020.12.012] [Reference Citation Analysis]
155 Misra RS, Nayak JL. The Importance of Vaccinating Children and Pregnant Women against Influenza Virus Infection. Pathogens 2019;8:E265. [PMID: 31779153 DOI: 10.3390/pathogens8040265] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
156 Öztelcan Gündüz B, Ataş E, Ünay B, Halil H. Evaluation of Influenza Patients Admitted in 2019–2020 Flu Season. J Pediatr Infect Dis. [DOI: 10.1055/s-0041-1741003] [Reference Citation Analysis]
157 Tarasov M, Shanko A, Kordyukova L, Katlinski A. Characterization of Inactivated Influenza Vaccines Used in the Russian National Immunization Program. Vaccines (Basel) 2020;8:E488. [PMID: 32872645 DOI: 10.3390/vaccines8030488] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
158 Panagiotakopoulos L, McCarthy NL, Tepper NK, Kharbanda EO, Lipkind HS, Vazquez-Benitez G, McClure DL, Greenberg V, Getahun D, Glanz JM, Naleway AL, Klein NP, Nelson JC, Weintraub ES. Evaluating the Association of Stillbirths After Maternal Vaccination in the Vaccine Safety Datalink. Obstet Gynecol 2020;136:1086-94. [PMID: 33156197 DOI: 10.1097/AOG.0000000000004166] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
159 Ababneh M, Jaber M, Rababa'h A, Ababneh F. Seasonal influenza vaccination among older adults in Jordan: prevalence, knowledge, and attitudes. Hum Vaccin Immunother 2020;16:2252-6. [PMID: 32045332 DOI: 10.1080/21645515.2020.1718438] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
160 Yedlapati SH, Khan SU, Talluri S, Lone AN, Khan MZ, Khan MS, Navar AM, Gulati M, Johnson H, Baum S, Michos ED. Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis. J Am Heart Assoc 2021;10:e019636. [PMID: 33719496 DOI: 10.1161/JAHA.120.019636] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
161 Kim BY, Yung Y, Kim GS, Park HR, Lee JJ, Song P, Cho JY. Complete Oculomotor Palsy after Influenza Vaccination in a Young Healthy Adult: A Case Report. Case Rep Neurol 2021;13:35-9. [PMID: 33613242 DOI: 10.1159/000511025] [Reference Citation Analysis]
162 Nassar AH, Visser GHA, Nicholson WK, Ramasauskaite D, Kim YH, Barnea ER; FIGO Safe Motherhood, Newborn Health Committee. FIGO Statement: Vaccination in pregnancy. Int J Gynaecol Obstet 2021;152:139-43. [PMID: 33128249 DOI: 10.1002/ijgo.13456] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
163 Tenforde MW, Chung J, Smith ER, Talbot HK, Trabue CH, Zimmerman RK, Silveira FP, Gaglani M, Murthy K, Monto AS, Martin ET, McLean HQ, Belongia EA, Jackson LA, Jackson ML, Ferdinands JM, Flannery B, Patel MM. Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings in the United States, 2015-2018. Clin Infect Dis 2021;73:386-92. [PMID: 32270198 DOI: 10.1093/cid/ciaa407] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
164 Javier PF, Ramón DG, Ana EG, Alves MCM, Julia ABM. Attitude towards Vaccination among Health Science Students before the COVID-19 Pandemic. Vaccines (Basel) 2021;9:644. [PMID: 34204741 DOI: 10.3390/vaccines9060644] [Reference Citation Analysis]
165 Desheva Y, Leontieva G, Kramskaya T, Losev I, Petkova N, Rekstin A, Suvorov A. Associated virus-bacterial vaccine based on seasonal LAIV and S. pneumoniae chimeric peptide provide protection against post-influenza pneumococcal infection in mouse model. Virulence 2022;13:558-68. [PMID: 35266442 DOI: 10.1080/21505594.2022.2049496] [Reference Citation Analysis]
166 Roy B, Litchman T, Torabi T, Nowak RJ. Influenza vaccination in autoimmune neuromuscular diseases: A survey of current practices and perceptions. Muscle Nerve 2021;63:918-23. [PMID: 33711167 DOI: 10.1002/mus.27224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
167 Behrouzi B, Araujo Campoverde MV, Liang K, Talbot HK, Bogoch II, McGeer A, Fröbert O, Loeb M, Vardeny O, Solomon SD, Udell JA. Influenza Vaccination to Reduce Cardiovascular Morbidity and Mortality in Patients With COVID-19: JACC State-of-the-Art Review. J Am Coll Cardiol 2020;76:1777-94. [PMID: 33032740 DOI: 10.1016/j.jacc.2020.08.028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
168 Antonelli M, Donelli D, Firenzuoli F. Ginseng integrative supplementation for seasonal acute upper respiratory infections: A systematic review and meta-analysis. Complement Ther Med 2020;52:102457. [PMID: 32951718 DOI: 10.1016/j.ctim.2020.102457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
169 Marathe BM, Asthagiri Arunkumar G, Vogel P, Pascua PNQ, Jones J, Webby RJ, Krammer F, Govorkova EA. Monoclonal Antibody Therapy Protects Pharmacologically Immunosuppressed Mice from Lethal Infection with Influenza B Virus. Antimicrob Agents Chemother 2020;64:e00284-20. [PMID: 32631823 DOI: 10.1128/AAC.00284-20] [Reference Citation Analysis]
170 Alem K, Hsu T. Prevalence of bacterial pneumonia among HIV-Seropositive patients in East Africa: Review. Cogent Medicine 2021;8:2015883. [DOI: 10.1080/2331205x.2021.2015883] [Reference Citation Analysis]
171 Kondratiuk K, Hallmann E, Łuniewska K, Szymański K, Brydak L. Epidemiology of Influenza Viruses and Viruses Causing Influenza-Like Illness in Children Under 14 Years Old in the 2018-2019 Epidemic Season in Poland. Med Sci Monit 2021;27:e929303. [PMID: 33966032 DOI: 10.12659/MSM.929303] [Reference Citation Analysis]
172 Lorini C, Lastrucci V, Zanella B, Gori E, Chiesi F, Bechini A, Boccalini S, Del Riccio M, Moscadelli A, Puggelli F, Berti R, Bonanni P, Bonaccorsi G. Predictors of Influenza Vaccination Uptake and the Role of Health Literacy among Health and Social Care Volunteers in the Province of Prato (Italy). Int J Environ Res Public Health 2022;19:6688. [PMID: 35682272 DOI: 10.3390/ijerph19116688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
173 Song Y, Li S, Xiao W, Shen J, Ma W, Wang Q, Yang H, Liu G, Hong Y, Li P, Yang S. Influenza-Associated Encephalopathy and Acute Necrotizing Encephalopathy in Children: A Retrospective Single-Center Study. Med Sci Monit 2021;27:e928374. [PMID: 33388740 DOI: 10.12659/MSM.928374] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
174 Levin MJ, Divino V, Shah D, DeKoven M, Mould-Quevedo J, Pelton SI, Postma MJ. Comparing the Clinical and Economic Outcomes Associated with Adjuvanted versus High-Dose Trivalent Influenza Vaccine among Adults Aged ≥ 65 Years in the US during the 2019-20 Influenza Season-A Retrospective Cohort Analysis. Vaccines (Basel) 2021;9:1146. [PMID: 34696254 DOI: 10.3390/vaccines9101146] [Reference Citation Analysis]
175 Krenitsky N, Friedman AM, Yu K, Gyamfi-Bannerman C, Williams-Kane J, O'Shaugnessy F, Huang Y, Wright JD, D'Alton ME, Wen T. Trends in Venous Thromboembolism and Associated Risk Factors During Delivery Hospitalizations From 2000 to 2018. Obstet Gynecol 2022;139:223-34. [PMID: 34991111 DOI: 10.1097/AOG.0000000000004648] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
176 Whitaker JA. Immunization Strategies to Span the Spectrum of Immunocompromised Adults. Mayo Clin Proc 2020;95:1530-48. [PMID: 32067801 DOI: 10.1016/j.mayocp.2019.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
177 Marinelli TM, Kumar D. Influenza Virus Infection and Transplantation. Transplantation 2021;105:968-78. [PMID: 33044429 DOI: 10.1097/TP.0000000000003486] [Reference Citation Analysis]
178 Li Y, Wang LL, Xie LL, Hou WL, Liu XY, Yin S. The epidemiological and clinical characteristics of the hospital-acquired influenza infections: A systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e25142. [PMID: 33725996 DOI: 10.1097/MD.0000000000025142] [Reference Citation Analysis]
179 Shehata MM, Kandeil A, Mostafa A, Mahmoud SH, Gomaa MR, El-Shesheny R, Webby R, Kayali G, Ali MA. A Recombinant Influenza A/H1N1 Carrying A Short Immunogenic Peptide of MERS-CoV as Bivalent Vaccine in BALB/c Mice. Pathogens 2019;8:E281. [PMID: 31810359 DOI: 10.3390/pathogens8040281] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
180 Miskulin DC. Influenza in dialysis patients: an opportunity to decrease mortality? Curr Opin Nephrol Hypertens 2019;28:607-14. [PMID: 31567466 DOI: 10.1097/MNH.0000000000000550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
181 Boikos C, Mcgovern I, Molrine D, Ortiz JR, Puig-barberà J, Haag M. Review of Analyses Estimating Relative Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Three Consecutive US Influenza Seasons. Vaccines 2022;10:896. [DOI: 10.3390/vaccines10060896] [Reference Citation Analysis]
182 Mattila JM, Thomas E, Lehtinen P, Vuorinen T, Waris M, Heikkinen T. Burden of influenza during the first year of life. Influenza Other Respir Viruses 2021;15:506-12. [PMID: 33073478 DOI: 10.1111/irv.12820] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
183 Casella G, Ingravalle F, Ingravalle A, Monti C, Bonetti F, De Salvatore F, Villanacci V, Limonta A. Vaccination in Inflammatory Bowel Disease: Utility and Future Perspective. GastrointestDisord 2020;2:175-92. [DOI: 10.3390/gidisord2020019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
184 Mok DZL, Chan KR. The Effects of Pre-Existing Antibodies on Live-Attenuated Viral Vaccines. Viruses 2020;12:E520. [PMID: 32397218 DOI: 10.3390/v12050520] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
185 Domnich A, Cambiaggi M, Vasco A, Maraniello L, Ansaldi F, Baldo V, Bonanni P, Calabrò GE, Costantino C, de Waure C, Gabutti G, Restivo V, Rizzo C, Vitale F, Grassi R. Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian Survey. Vaccines (Basel) 2020;8:E711. [PMID: 33266212 DOI: 10.3390/vaccines8040711] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
186 Mohme S, Schmalzing M, Müller CSL, Vogt T, Goebeler M, Stoevesandt J. Impfen bei Immunsuppression: ein Leitfaden für die dermatologische Praxis. J Dtsch Dermatol Ges 2020;18:699-725. [PMID: 32713144 DOI: 10.1111/ddg.14156_g] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
187 Haddadin Z, Krueger K, Thomas LD, Overton ET, Ison M, Halasa N. Alternative strategies of posttransplant influenza vaccination in adult solid organ transplant recipients. Am J Transplant 2021;21:938-49. [PMID: 32885604 DOI: 10.1111/ajt.16295] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 9.5] [Reference Citation Analysis]
188 Ishaqui AA, Khan AH, Sulaiman SA, Alsultan M, Khan I. Efficacy comparison of oseltamivir alone and oseltamivir-antibiotic combination for early resolution of symptoms of severe influenza-A and influenza-B hospitalized patients. Saudi Med J 2020;41:1015-21. [PMID: 32893285 DOI: 10.15537/smj.2020.9.25249] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
189 Bekelis K, Missios S, Ahmad J, Labropoulos N, Schirmer CM, Calnan DR, Skinner J, MacKenzie TA. Ischemic Stroke Occurs Less Frequently in Patients With COVID-19: A Multicenter Cross-Sectional Study. Stroke 2020;51:3570-6. [PMID: 33106109 DOI: 10.1161/STROKEAHA.120.031217] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
190 Rguig A, Cherkaoui I, McCarron M, Oumzil H, Triki S, Elmbarki H, Bimouhen A, El Falaki F, Regragui Z, Ihazmad H, Nejjari C, Youbi M. Establishing seasonal and alert influenza thresholds in Morocco. BMC Public Health 2020;20:1029. [PMID: 32600376 DOI: 10.1186/s12889-020-09145-y] [Reference Citation Analysis]
191 Yonas E, Alwi I, Pranata R, Huang I, Lim MA, Gutierrez EJ, Yamin M, Siswanto BB, Virani SS. Effect of heart failure on the outcome of COVID-19 — A meta analysis and systematic review. The American Journal of Emergency Medicine 2021;46:204-11. [DOI: 10.1016/j.ajem.2020.07.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 32.0] [Reference Citation Analysis]
192 Romano CJ, Hall C, Khodr ZG, Bukowinski AT, Gumbs GR, Conlin AMS. History of pandemic H1N1-containing influenza vaccination and risk for spontaneous abortion and birth defects. Vaccine 2021;39:6553-62. [PMID: 34598819 DOI: 10.1016/j.vaccine.2021.09.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
193 Damjanovska S, Smith C, Sayin I, Burant CJ, Gravenstein S, Canaday DH. Adjuvant effect of type I interferon induced by many but not all commercial influenza vaccines. Vaccine 2021;39:786-9. [PMID: 33390292 DOI: 10.1016/j.vaccine.2020.12.051] [Reference Citation Analysis]
194 de St Maurice A, Halasa N. Preparing for the 2019-2020 influenza season. Pediatr Transplant 2020;24:e13645. [PMID: 31885157 DOI: 10.1111/petr.13645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
195 Tokars JI, Patel MM, Foppa IM, Reed C, Fry AM, Ferdinands JM. Waning of Measured Influenza Vaccine Effectiveness Over Time: The Potential Contribution of Leaky Vaccine Effect. Clin Infect Dis 2020;71:e633-41. [PMID: 32227109 DOI: 10.1093/cid/ciaa340] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
196 Karaarslan U, Topal S, Ayhan Y, Ağın H. The Differences in Viral Etiologies between Children with and without Severe Disability Admitted to the Pediatric Intensive Care Unit with Acute Respiratory Illness. Journal of Pediatric Infectious Diseases 2021;16:001-6. [DOI: 10.1055/s-0040-1718541] [Reference Citation Analysis]
197 Orenstein EW, ElSayed-Ali O, Kandaswamy S, Masterson E, Blanco R, Shah P, Lantis P, Kolwaite A, Dawson TE, Ray E, Bryant C, Iyer S, Shane AL, Jernigan S. Evaluation of a Clinical Decision Support Strategy to Increase Seasonal Influenza Vaccination Among Hospitalized Children Before Inpatient Discharge. JAMA Netw Open 2021;4:e2117809. [PMID: 34292335 DOI: 10.1001/jamanetworkopen.2021.17809] [Reference Citation Analysis]
198 Regan AK, Håberg SE, Fell DB. Current Perspectives on Maternal Influenza Immunization. Curr Trop Med Rep 2019;6:239-49. [DOI: 10.1007/s40475-019-00188-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
199 Weinberg GA. Nontraditional Uses of Live Attenuated Influenza Vaccine: School-Located Influenza Vaccination. Journal of the Pediatric Infectious Diseases Society 2020;9:S19-23. [DOI: 10.1093/jpids/piaa007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
200 Kirkpatrick Roubidoux E, Sano K, McMahon M, Carreño JM, Capuano C, Jiang K, Simon V, van Bakel H, Wilson P, Krammer F. Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies. J Virol 2022;:e0033222. [PMID: 35446141 DOI: 10.1128/jvi.00332-22] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
201 Dhar R, Ghoshal AG, Guleria R, Sharma S, Kulkarni T, Swarnakar R, Samaria JK, Chaudhary S, Gaur SN, Christopher DJ, Singh V, Abraham G, Sarkar A, Mukhopadhyay A, Panda J, Swaminathan S, Nene A, Krishnan S, Shahi PK, Sarangdhar N, Mishra N, Chowdury SR, Halder I, Katiyar SK, Jain VK, Chawla R, Koul PA. Clinical practice guidelines 2019: Indian consensus-based recommendations on influenza vaccination in adults. Lung India 2020;37:S4-S18. [PMID: 32830789 DOI: 10.4103/lungindia.lungindia_270_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
202 Lytle KL, Collins SP, Feldstein LR, Baughman AH, Brown SM, Casey JD, Erickson HL, Exline MC, Files DC, Gibbs KW, Ginde AA, Gong MN, Grijalva CG, Khan A, Lindsell CJ, Peltan ID, Prekker ME, Rice TW, Shapiro NI, Steingrub JS, Stubblefield WB, Tenforde MW, Womack KN, Patel MM, Self WH; Influenza and Other Viruses in the Acutely Ill (IVY) Network. Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019-2020. Vaccine 2021;39:5271-6. [PMID: 34376307 DOI: 10.1016/j.vaccine.2021.07.057] [Reference Citation Analysis]
203 Daemi HB, Kulyar MF, He X, Li C, Karimpour M, Sun X, Zou Z, Jin M. Progression and Trends in Virus from Influenza A to COVID-19: An Overview of Recent Studies. Viruses 2021;13:1145. [PMID: 34203647 DOI: 10.3390/v13061145] [Reference Citation Analysis]
204 Langley J, Pastural E, Halperin S, McNeil S, ElSherif M, MacKinnon-Cameron D, Ye L, Grange C, Thibodeau V, Cailhier JF, Lapointe R, McElhaney J, Martin L, Bolduc M, Laliberté-Gagné ME, Leclerc D, Savard P. A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18-50 Years of Age. Vaccines (Basel) 2020;8:E393. [PMID: 32698532 DOI: 10.3390/vaccines8030393] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
205 Cambou MC, Copeland TP, Nielsen-Saines K, Macinko J. Insurance status predicts self-reported influenza vaccine coverage among pregnant women in the United States: A cross-sectional analysis of the National Health Interview Study Data from 2012 to 2018. Vaccine 2021;39:2068-73. [PMID: 33744045 DOI: 10.1016/j.vaccine.2021.03.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
206 Rao S, Lamb MM, Moss A, Mistry RD, Grice K, Ahmed W, Santos-Cantu D, Kitchen E, Patel C, Ferrari I, Dominguez SR. Effect of Rapid Respiratory Virus Testing on Antibiotic Prescribing Among Children Presenting to the Emergency Department With Acute Respiratory Illness: A Randomized Clinical Trial. JAMA Netw Open 2021;4:e2111836. [PMID: 34086034 DOI: 10.1001/jamanetworkopen.2021.11836] [Reference Citation Analysis]
207 Desheva Y, Leontieva G, Kramskaya T, Losev I, Rekstin A, Petkova N, Kudar P, Suvorov A. Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice. Microorganisms 2022;10:1150. [DOI: 10.3390/microorganisms10061150] [Reference Citation Analysis]
208 Landgraf G, Desheva YA, Rudenko LG. Assessment of trivalent live influenza vaccines in MDCK cell line. MethodsX 2021;8:101442. [PMID: 34430331 DOI: 10.1016/j.mex.2021.101442] [Reference Citation Analysis]
209 Landgraf G, Desheva YA, Rudenko LG. Evaluation of influenza A and B cold-adapted reassortant virus reproduction in trivalent live influenza vaccines. Virus Res 2021;300:198396. [PMID: 33744337 DOI: 10.1016/j.virusres.2021.198396] [Reference Citation Analysis]
210 Ferrero MR, Tavares LP, Garcia CC. The Dual Role of CCR5 in the Course of Influenza Infection: Exploring Treatment Opportunities. Front Immunol 2022;12:826621. [DOI: 10.3389/fimmu.2021.826621] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
211 Temte JL, Barlow S, Goss M, Temte E, Bell C, He C, Hamer C, Schemmel A, Maerz B, Comp L, Arnold M, Breunig K, Clifford S, Reisdorf E, Shult P, Wedig M, Haupt T, Conway J, Gangnon R, Fowlkes A, Uzicanin A. The Oregon Child Absenteeism Due to Respiratory Disease Study (ORCHARDS): Rationale, objectives, and design. Influenza Other Respir Viruses 2021. [PMID: 34623760 DOI: 10.1111/irv.12920] [Reference Citation Analysis]
212 Tapia-Conyer R, Betancourt-Cravioto M, Montoya A, Falcón-Lezama JA, Alfaro-Cortes MM, Saucedo-Martínez R. A Call for a Reform of the Influenza Immunization Program in Mexico: Epidemiologic and Economic Evidence for Decision Making. Vaccines (Basel) 2021;9:286. [PMID: 33808916 DOI: 10.3390/vaccines9030286] [Reference Citation Analysis]
213 Dąbek J, Sierka O, Kulik H, Gąsior Z. Protective vaccinations during pregnancy - adult Poles knowledge in this area. BMC Public Health 2021;21:1392. [PMID: 34256706 DOI: 10.1186/s12889-021-11336-0] [Reference Citation Analysis]
214 Checkmahomed L, Padey B, Pizzorno A, Terrier O, Rosa-Calatrava M, Abed Y, Baz M, Boivin G. In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses. Viruses 2020;12:E1139. [PMID: 33049959 DOI: 10.3390/v12101139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
215 Velasco-Medina AA, García-León ML, Velázquez-Sámano G, Wong-Chew RM. The cellular and humoral immune response to influenza vaccination is comparable in asthmatic and healthy subjects. Hum Vaccin Immunother 2021;17:98-105. [PMID: 32437230 DOI: 10.1080/21645515.2020.1759995] [Reference Citation Analysis]